Register Login

Dabigatran May Shorten Hospital Stay

The posted a small but powerful study today illustrating that dabigatran (Pradaxa) may shorten the inpatient stay because it eliminates the need for coverage by heparin or fondaparinux and eliminates the need to tinker with dosage to hit the target international normalized ratio (INR). Yet more good new for dabigatran. Geo.

Comments (0)
Anticoagulant Therapy

No comments here.

Leave a Reply